tb500 vs bpc 157 differences BPC-157 TB-500: Comprehensive Comparison of Recovery and Healing Peptides for Research Peptides for Recovery: TB500 vs
Description
Phase 1/2 trial reported no serious adverse events at doses up to 60 mcg/kg (Teichman et al., J Clin Endocrinol Metab 2006)
It took me a good two weeks to make the decision to start this medication
Injectable BPC-157 reaches tissue concentrations the oral route cannot match for most non-gut uses
Petrovic et al., 2011
